Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib and Everolimus Prior to Nephrectomy in RCC
NCT03324373Phase 1Completed
- Start
- Mar 2019
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of lenvatinib and everolimus in renal cell carcinoma (RCC). Started Mar 2019; status: completed.
02
Drugs
lenvatinibeverolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT03324373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324373.